Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Surgical Procedures | 28 | 2021 | 1490 | 3.610 |
Why?
|
Arteriovenous Shunt, Surgical | 12 | 2023 | 292 | 2.660 |
Why?
|
Graft Occlusion, Vascular | 16 | 2024 | 537 | 2.540 |
Why?
|
Veins | 20 | 2024 | 768 | 2.510 |
Why?
|
Carotid Stenosis | 12 | 2021 | 860 | 2.220 |
Why?
|
Diet, Protein-Restricted | 5 | 2020 | 73 | 2.200 |
Why?
|
Carotid Artery, Common | 9 | 2020 | 175 | 2.040 |
Why?
|
Tunica Intima | 14 | 2021 | 459 | 1.990 |
Why?
|
Vena Cava, Inferior | 7 | 2021 | 459 | 1.920 |
Why?
|
Caloric Restriction | 8 | 2021 | 299 | 1.900 |
Why?
|
Vascular Patency | 20 | 2023 | 910 | 1.570 |
Why?
|
Blood Vessel Prosthesis | 18 | 2023 | 954 | 1.480 |
Why?
|
Endarterectomy, Carotid | 8 | 2019 | 555 | 1.440 |
Why?
|
Renal Dialysis | 15 | 2024 | 1801 | 1.360 |
Why?
|
Blood Vessel Prosthesis Implantation | 17 | 2023 | 1427 | 1.330 |
Why?
|
Preoperative Care | 7 | 2019 | 2242 | 1.230 |
Why?
|
Arteriovenous Fistula | 5 | 2024 | 319 | 1.160 |
Why?
|
Vascular Grafting | 7 | 2024 | 162 | 1.120 |
Why?
|
Subcutaneous Fat | 4 | 2014 | 393 | 1.120 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2022 | 1230 | 1.020 |
Why?
|
Neointima | 5 | 2020 | 133 | 0.950 |
Why?
|
Peripheral Arterial Disease | 10 | 2024 | 1272 | 0.930 |
Why?
|
Lower Extremity | 10 | 2018 | 1201 | 0.900 |
Why?
|
Hyperplasia | 19 | 2021 | 1153 | 0.900 |
Why?
|
Radial Artery | 4 | 2022 | 186 | 0.860 |
Why?
|
Cystathionine gamma-Lyase | 4 | 2020 | 36 | 0.800 |
Why?
|
Hydrogen Sulfide | 7 | 2021 | 141 | 0.790 |
Why?
|
Surgical Wound Dehiscence | 3 | 2017 | 213 | 0.770 |
Why?
|
Methionine | 3 | 2024 | 572 | 0.750 |
Why?
|
Wound Healing | 11 | 2021 | 2802 | 0.740 |
Why?
|
Carotid Arteries | 13 | 2023 | 941 | 0.730 |
Why?
|
Jugular Veins | 6 | 2009 | 210 | 0.700 |
Why?
|
Interleukin-1 | 4 | 2012 | 1250 | 0.670 |
Why?
|
Surgical Wound Infection | 7 | 2021 | 1525 | 0.660 |
Why?
|
Bandages | 2 | 2014 | 269 | 0.660 |
Why?
|
Polyesters | 2 | 2014 | 374 | 0.660 |
Why?
|
Leg | 7 | 2013 | 1089 | 0.650 |
Why?
|
Polyethylenes | 2 | 2014 | 290 | 0.630 |
Why?
|
Blood Vessels | 3 | 2018 | 1113 | 0.620 |
Why?
|
Graft Survival | 10 | 2021 | 3818 | 0.610 |
Why?
|
Peripheral Vascular Diseases | 5 | 2013 | 488 | 0.590 |
Why?
|
Hindlimb | 2 | 2018 | 512 | 0.580 |
Why?
|
Ultrasonography, Doppler, Duplex | 3 | 2022 | 198 | 0.580 |
Why?
|
Specialty Boards | 1 | 2019 | 235 | 0.570 |
Why?
|
Adiponectin | 4 | 2016 | 1113 | 0.570 |
Why?
|
Reperfusion Injury | 4 | 2018 | 1023 | 0.560 |
Why?
|
Brachial Artery | 2 | 2023 | 366 | 0.560 |
Why?
|
Hemodynamics | 7 | 2014 | 4167 | 0.540 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2013 | 4355 | 0.530 |
Why?
|
Adipose Tissue | 6 | 2021 | 3310 | 0.530 |
Why?
|
Limb Salvage | 7 | 2024 | 481 | 0.520 |
Why?
|
Upper Extremity | 2 | 2019 | 657 | 0.520 |
Why?
|
Microscopy, Acoustic | 2 | 2013 | 47 | 0.510 |
Why?
|
Time Factors | 40 | 2023 | 39974 | 0.500 |
Why?
|
Forearm | 3 | 2024 | 427 | 0.500 |
Why?
|
Silver Compounds | 1 | 2014 | 23 | 0.480 |
Why?
|
Ischemia | 11 | 2018 | 1876 | 0.480 |
Why?
|
Alginates | 2 | 2022 | 248 | 0.470 |
Why?
|
Silk | 1 | 2014 | 90 | 0.450 |
Why?
|
Matrix Metalloproteinase 2 | 3 | 2009 | 459 | 0.440 |
Why?
|
Inflammation Mediators | 6 | 2015 | 1886 | 0.430 |
Why?
|
Vascular System Injuries | 1 | 2017 | 246 | 0.430 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2021 | 942 | 0.430 |
Why?
|
Disease Models, Animal | 16 | 2021 | 18234 | 0.430 |
Why?
|
Matrix Metalloproteinase 9 | 4 | 2012 | 632 | 0.430 |
Why?
|
Elastin | 1 | 2014 | 299 | 0.420 |
Why?
|
Biomimetic Materials | 1 | 2014 | 172 | 0.410 |
Why?
|
Receptors, Interleukin-1 Type I | 1 | 2012 | 30 | 0.410 |
Why?
|
Femoral Artery | 7 | 2021 | 827 | 0.410 |
Why?
|
Mice, Inbred C57BL | 20 | 2024 | 22154 | 0.400 |
Why?
|
Hemorheology | 3 | 2011 | 144 | 0.400 |
Why?
|
Tunica Media | 1 | 2012 | 112 | 0.400 |
Why?
|
Cytokines | 4 | 2021 | 7390 | 0.400 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 247 | 0.400 |
Why?
|
Arterial Occlusive Diseases | 7 | 2019 | 748 | 0.390 |
Why?
|
Polytetrafluoroethylene | 5 | 2023 | 246 | 0.390 |
Why?
|
Interdisciplinary Communication | 2 | 2019 | 931 | 0.390 |
Why?
|
Uremia | 1 | 2012 | 201 | 0.380 |
Why?
|
Regional Blood Flow | 8 | 2017 | 1495 | 0.370 |
Why?
|
Rabbits | 16 | 2015 | 4779 | 0.370 |
Why?
|
Male | 94 | 2024 | 360621 | 0.370 |
Why?
|
Animals | 61 | 2024 | 168388 | 0.350 |
Why?
|
Comparative Effectiveness Research | 3 | 2023 | 709 | 0.350 |
Why?
|
Hyperglycemia | 1 | 2018 | 1375 | 0.340 |
Why?
|
Endovascular Procedures | 9 | 2022 | 2181 | 0.340 |
Why?
|
Health Priorities | 1 | 2013 | 374 | 0.340 |
Why?
|
Adaptation, Physiological | 4 | 2012 | 1301 | 0.340 |
Why?
|
Leptin | 6 | 2021 | 1595 | 0.330 |
Why?
|
Patient Care Team | 2 | 2019 | 2523 | 0.320 |
Why?
|
Treatment Outcome | 39 | 2023 | 64645 | 0.310 |
Why?
|
Amputation Stumps | 1 | 2008 | 38 | 0.310 |
Why?
|
Ferric Compounds | 1 | 2010 | 378 | 0.310 |
Why?
|
Dietary Fats | 2 | 2013 | 1994 | 0.310 |
Why?
|
Iliac Artery | 4 | 2019 | 343 | 0.310 |
Why?
|
Length of Stay | 8 | 2021 | 6422 | 0.310 |
Why?
|
Resistin | 3 | 2013 | 172 | 0.300 |
Why?
|
Magnetics | 1 | 2010 | 599 | 0.290 |
Why?
|
Blood Flow Velocity | 7 | 2017 | 1370 | 0.290 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2373 | 0.280 |
Why?
|
Forefoot, Human | 1 | 2006 | 31 | 0.280 |
Why?
|
Fibroblasts | 3 | 2017 | 4139 | 0.270 |
Why?
|
Proteins | 1 | 2021 | 6034 | 0.270 |
Why?
|
Cardiovascular Agents | 1 | 2013 | 840 | 0.270 |
Why?
|
Interleukin-10 | 4 | 2007 | 1175 | 0.270 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 877 | 0.270 |
Why?
|
Aged | 51 | 2024 | 169179 | 0.270 |
Why?
|
Stents | 2 | 2018 | 3179 | 0.260 |
Why?
|
Mice | 30 | 2024 | 81474 | 0.260 |
Why?
|
Collagen | 1 | 2014 | 2638 | 0.260 |
Why?
|
Vascular Diseases | 2 | 2013 | 1161 | 0.250 |
Why?
|
Reoperation | 8 | 2023 | 4302 | 0.250 |
Why?
|
Inflammation | 3 | 2014 | 10760 | 0.240 |
Why?
|
Shear Strength | 5 | 2009 | 160 | 0.240 |
Why?
|
RNA, Messenger | 8 | 2012 | 12787 | 0.240 |
Why?
|
Patient Discharge | 3 | 2016 | 3438 | 0.240 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2013 | 277 | 0.230 |
Why?
|
Prosthesis-Related Infections | 4 | 2021 | 488 | 0.230 |
Why?
|
Cell Movement | 4 | 2015 | 5202 | 0.230 |
Why?
|
Stroke | 5 | 2015 | 9749 | 0.230 |
Why?
|
Hospitals, Veterans | 1 | 2006 | 395 | 0.230 |
Why?
|
Humans | 99 | 2024 | 761326 | 0.230 |
Why?
|
Female | 69 | 2024 | 392485 | 0.220 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3419 | 0.220 |
Why?
|
Risk Factors | 32 | 2024 | 74152 | 0.220 |
Why?
|
Middle Aged | 52 | 2024 | 220774 | 0.220 |
Why?
|
Diet | 4 | 2021 | 8074 | 0.220 |
Why?
|
Mice, Knockout | 12 | 2021 | 14409 | 0.220 |
Why?
|
Neovascularization, Physiologic | 4 | 2018 | 1344 | 0.210 |
Why?
|
Saphenous Vein | 4 | 2015 | 518 | 0.210 |
Why?
|
Prospective Studies | 22 | 2022 | 54405 | 0.210 |
Why?
|
Boston | 5 | 2021 | 9333 | 0.210 |
Why?
|
Groin | 2 | 2021 | 106 | 0.210 |
Why?
|
Pancreatic Elastase | 2 | 2021 | 128 | 0.200 |
Why?
|
Postoperative Complications | 14 | 2022 | 15647 | 0.200 |
Why?
|
Osteomyelitis | 1 | 2006 | 407 | 0.200 |
Why?
|
Macrophages | 7 | 2024 | 5768 | 0.200 |
Why?
|
Patient Readmission | 6 | 2021 | 3267 | 0.200 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 2 | 2017 | 151 | 0.200 |
Why?
|
Arteries | 3 | 2006 | 1125 | 0.200 |
Why?
|
Polyethylene Terephthalates | 4 | 1995 | 115 | 0.190 |
Why?
|
Stress, Mechanical | 4 | 2013 | 1674 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2018 | 823 | 0.190 |
Why?
|
Energy Intake | 3 | 2021 | 2134 | 0.190 |
Why?
|
Captopril | 1 | 2021 | 265 | 0.190 |
Why?
|
Nutritional Status | 2 | 2020 | 1613 | 0.190 |
Why?
|
Phenotype | 3 | 2014 | 16603 | 0.180 |
Why?
|
Societies, Medical | 1 | 2013 | 3905 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2005 | 584 | 0.180 |
Why?
|
Diet Therapy | 1 | 2021 | 150 | 0.180 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 3 | 2007 | 256 | 0.180 |
Why?
|
Up-Regulation | 2 | 2007 | 4120 | 0.180 |
Why?
|
Immunity, Innate | 1 | 2012 | 3060 | 0.180 |
Why?
|
Endarterectomy | 1 | 2021 | 196 | 0.180 |
Why?
|
Databases, Factual | 6 | 2023 | 7954 | 0.180 |
Why?
|
Systems Analysis | 1 | 2021 | 169 | 0.170 |
Why?
|
Models, Animal | 4 | 2010 | 2112 | 0.170 |
Why?
|
PPAR alpha | 1 | 2021 | 175 | 0.170 |
Why?
|
Bilophila | 1 | 2019 | 12 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 180 | 0.170 |
Why?
|
Receptors, LDL | 2 | 2020 | 490 | 0.170 |
Why?
|
Malaria, Cerebral | 1 | 2021 | 136 | 0.170 |
Why?
|
Cholesterol, Dietary | 1 | 2020 | 224 | 0.170 |
Why?
|
Enzyme Induction | 1 | 2020 | 451 | 0.170 |
Why?
|
Wrist | 1 | 2021 | 227 | 0.160 |
Why?
|
Ligation | 5 | 2021 | 448 | 0.160 |
Why?
|
Hospital Costs | 2 | 2016 | 948 | 0.160 |
Why?
|
Obesity | 4 | 2014 | 12934 | 0.160 |
Why?
|
Magnetic Resonance Angiography | 2 | 2011 | 1432 | 0.160 |
Why?
|
After-Hours Care | 1 | 2019 | 102 | 0.160 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2021 | 156 | 0.160 |
Why?
|
Nanoparticles | 1 | 2010 | 1955 | 0.160 |
Why?
|
Adipose Tissue, Brown | 1 | 2024 | 764 | 0.160 |
Why?
|
Endothelial Cells | 5 | 2018 | 3543 | 0.160 |
Why?
|
Amino Acids, Sulfur | 1 | 2018 | 16 | 0.160 |
Why?
|
Parasites | 1 | 2021 | 160 | 0.150 |
Why?
|
Retrospective Studies | 31 | 2024 | 80575 | 0.150 |
Why?
|
Chemokine CCL2 | 3 | 2013 | 604 | 0.150 |
Why?
|
Cerebral Angiography | 2 | 2014 | 1281 | 0.150 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12059 | 0.150 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2015 | 1493 | 0.150 |
Why?
|
Lipoproteins, VLDL | 1 | 2018 | 201 | 0.150 |
Why?
|
Laser-Doppler Flowmetry | 2 | 2012 | 239 | 0.150 |
Why?
|
Activating Transcription Factor 4 | 1 | 2018 | 84 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 8 | 2017 | 6473 | 0.150 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 2 | 2007 | 8 | 0.150 |
Why?
|
Aged, 80 and over | 17 | 2020 | 58946 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 395 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2014 | 1112 | 0.140 |
Why?
|
Biomedical Research | 1 | 2013 | 3429 | 0.140 |
Why?
|
Pilot Projects | 4 | 2019 | 8632 | 0.140 |
Why?
|
Device Removal | 2 | 2018 | 630 | 0.140 |
Why?
|
Seroma | 1 | 2017 | 75 | 0.140 |
Why?
|
Phlebotomy | 2 | 2008 | 137 | 0.140 |
Why?
|
Models, Cardiovascular | 3 | 2008 | 985 | 0.140 |
Why?
|
Administration, Topical | 2 | 2019 | 703 | 0.140 |
Why?
|
Transplants | 2 | 2009 | 207 | 0.140 |
Why?
|
Kidney Failure, Chronic | 4 | 2021 | 2471 | 0.130 |
Why?
|
Neovascularization, Pathologic | 2 | 2018 | 2644 | 0.130 |
Why?
|
Hypertension, Portal | 2 | 1989 | 226 | 0.130 |
Why?
|
Intermittent Claudication | 2 | 2015 | 304 | 0.130 |
Why?
|
Aortic Diseases | 2 | 2018 | 737 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 731 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 546 | 0.130 |
Why?
|
Intraoperative Care | 1 | 2019 | 766 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 997 | 0.130 |
Why?
|
Hematoma | 3 | 2017 | 768 | 0.130 |
Why?
|
Odds Ratio | 8 | 2017 | 9639 | 0.120 |
Why?
|
Amino Acids | 1 | 2021 | 1718 | 0.120 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2014 | 19 | 0.120 |
Why?
|
Frail Elderly | 1 | 2020 | 763 | 0.120 |
Why?
|
Aneurysm, False | 1 | 2017 | 254 | 0.120 |
Why?
|
Comprehension | 1 | 2020 | 621 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1517 | 0.120 |
Why?
|
Ciprofloxacin | 2 | 1993 | 312 | 0.120 |
Why?
|
Connexin 43 | 1 | 2015 | 200 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2014 | 150 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1650 | 0.120 |
Why?
|
Age Factors | 6 | 2014 | 18401 | 0.120 |
Why?
|
Risk Assessment | 15 | 2023 | 23981 | 0.120 |
Why?
|
Endothelium, Vascular | 3 | 2012 | 4432 | 0.120 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2014 | 40 | 0.120 |
Why?
|
Informed Consent | 1 | 2020 | 1008 | 0.110 |
Why?
|
Phenols | 1 | 2017 | 517 | 0.110 |
Why?
|
Foot Ulcer | 1 | 2014 | 63 | 0.110 |
Why?
|
Apoptosis | 3 | 2007 | 9474 | 0.110 |
Why?
|
Cell Proliferation | 5 | 2015 | 10431 | 0.110 |
Why?
|
Plant Lectins | 1 | 1993 | 103 | 0.110 |
Why?
|
Liver | 4 | 2018 | 7531 | 0.110 |
Why?
|
Anastomosis, Surgical | 4 | 2012 | 983 | 0.110 |
Why?
|
Texas | 1 | 2014 | 405 | 0.110 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 414 | 0.110 |
Why?
|
Autophagy | 1 | 2021 | 1321 | 0.110 |
Why?
|
Glycoconjugates | 1 | 1993 | 88 | 0.110 |
Why?
|
Edema | 1 | 2017 | 770 | 0.110 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 700 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1567 | 0.110 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1097 | 0.110 |
Why?
|
Gene Expression | 4 | 2012 | 7582 | 0.110 |
Why?
|
Adenosine Diphosphate | 1 | 2014 | 422 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.110 |
Why?
|
Feces | 1 | 2019 | 1495 | 0.100 |
Why?
|
Aorta, Abdominal | 3 | 2012 | 626 | 0.100 |
Why?
|
Subclavian Artery | 1 | 2013 | 134 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1115 | 0.100 |
Why?
|
Liver Transplantation | 3 | 2010 | 2333 | 0.100 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1121 | 0.100 |
Why?
|
Stress, Physiological | 3 | 2017 | 1403 | 0.100 |
Why?
|
Tissue Engineering | 2 | 2022 | 1872 | 0.100 |
Why?
|
Prostheses and Implants | 2 | 2018 | 1272 | 0.100 |
Why?
|
Patient Selection | 6 | 2018 | 4244 | 0.100 |
Why?
|
Efficiency, Organizational | 1 | 2016 | 695 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 3 | 2018 | 1529 | 0.100 |
Why?
|
Platelet Activation | 1 | 1995 | 645 | 0.100 |
Why?
|
Cohort Studies | 9 | 2023 | 41440 | 0.100 |
Why?
|
Workflow | 1 | 2016 | 851 | 0.100 |
Why?
|
Antigens, CD | 1 | 2002 | 4000 | 0.100 |
Why?
|
Signal Transduction | 6 | 2015 | 23427 | 0.100 |
Why?
|
Proportional Hazards Models | 6 | 2017 | 12450 | 0.100 |
Why?
|
Mesenteric Vascular Occlusion | 2 | 2002 | 92 | 0.090 |
Why?
|
Lectins | 1 | 1993 | 491 | 0.090 |
Why?
|
Popliteal Artery | 2 | 2012 | 310 | 0.090 |
Why?
|
Foot | 2 | 2014 | 575 | 0.090 |
Why?
|
History, 20th Century | 1 | 2019 | 2770 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 913 | 0.090 |
Why?
|
Program Evaluation | 2 | 2016 | 2494 | 0.090 |
Why?
|
Organizational Objectives | 1 | 2013 | 426 | 0.090 |
Why?
|
Capillary Permeability | 1 | 2014 | 774 | 0.090 |
Why?
|
Triglycerides | 1 | 2018 | 2458 | 0.090 |
Why?
|
Delayed-Action Preparations | 2 | 2012 | 962 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2019 | 1495 | 0.090 |
Why?
|
Homeostasis | 1 | 2021 | 3322 | 0.090 |
Why?
|
Fasting | 1 | 2017 | 1602 | 0.090 |
Why?
|
Hydrogen Peroxide | 1 | 2014 | 728 | 0.090 |
Why?
|
Polypharmacy | 1 | 2013 | 305 | 0.090 |
Why?
|
Cost-Benefit Analysis | 4 | 2016 | 5492 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2018 | 3489 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.090 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2010 | 120 | 0.090 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.090 |
Why?
|
Microvessels | 1 | 2014 | 575 | 0.090 |
Why?
|
Ampulla of Vater | 1 | 2010 | 149 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2683 | 0.090 |
Why?
|
Interleukin-8 | 1 | 2013 | 696 | 0.090 |
Why?
|
Dietary Proteins | 1 | 2015 | 952 | 0.090 |
Why?
|
Lactose Synthase | 1 | 1989 | 1 | 0.090 |
Why?
|
N-Acetyllactosamine Synthase | 1 | 1989 | 3 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2016 | 5247 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2007 | 11070 | 0.080 |
Why?
|
Ultrasonography | 4 | 2012 | 5970 | 0.080 |
Why?
|
Kidney | 3 | 2014 | 7049 | 0.080 |
Why?
|
Glucose | 1 | 2021 | 4345 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2012 | 943 | 0.080 |
Why?
|
Indoles | 1 | 2017 | 1832 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2021 | 4936 | 0.080 |
Why?
|
Hepatocyte Growth Factor | 1 | 2010 | 270 | 0.080 |
Why?
|
Portal Vein | 2 | 1992 | 431 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2012 | 589 | 0.080 |
Why?
|
Contrast Media | 3 | 2018 | 5310 | 0.080 |
Why?
|
United States | 12 | 2021 | 72317 | 0.080 |
Why?
|
Health Services Research | 1 | 2016 | 1811 | 0.080 |
Why?
|
Hemorrhage | 2 | 2018 | 3425 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2018 | 1900 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2014 | 804 | 0.080 |
Why?
|
Mesenteric Veins | 1 | 1989 | 86 | 0.080 |
Why?
|
Prosthesis Failure | 2 | 2018 | 1204 | 0.080 |
Why?
|
Receptors, CCR2 | 1 | 2009 | 215 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2775 | 0.080 |
Why?
|
Research Support as Topic | 1 | 2013 | 697 | 0.080 |
Why?
|
Ferritins | 2 | 2008 | 597 | 0.080 |
Why?
|
Linear Models | 3 | 2014 | 5871 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4567 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2642 | 0.080 |
Why?
|
Comorbidity | 5 | 2014 | 10498 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36430 | 0.080 |
Why?
|
Activities of Daily Living | 2 | 2008 | 2421 | 0.070 |
Why?
|
Interleukins | 1 | 2013 | 782 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2014 | 3592 | 0.070 |
Why?
|
Logistic Models | 4 | 2017 | 13251 | 0.070 |
Why?
|
Anesthesia | 1 | 2019 | 1592 | 0.070 |
Why?
|
Surface Properties | 1 | 2010 | 1160 | 0.070 |
Why?
|
Occlusive Dressings | 1 | 2007 | 52 | 0.070 |
Why?
|
Varicose Veins | 1 | 1989 | 155 | 0.070 |
Why?
|
Monocytes | 3 | 2006 | 2573 | 0.070 |
Why?
|
Pancreaticoduodenectomy | 1 | 2010 | 508 | 0.070 |
Why?
|
Apolipoproteins E | 1 | 2012 | 1444 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4793 | 0.070 |
Why?
|
Thrombosis | 2 | 2019 | 2942 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2010 | 2115 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2216 | 0.070 |
Why?
|
Ileum | 1 | 1989 | 557 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3597 | 0.070 |
Why?
|
Registries | 6 | 2021 | 8223 | 0.070 |
Why?
|
Reperfusion | 1 | 2007 | 270 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2760 | 0.070 |
Why?
|
Species Specificity | 1 | 2010 | 2419 | 0.060 |
Why?
|
Enzyme Precursors | 1 | 2006 | 174 | 0.060 |
Why?
|
Markov Chains | 3 | 2014 | 965 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2017 | 22124 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3741 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4014 | 0.060 |
Why?
|
Intestine, Small | 2 | 1989 | 1205 | 0.060 |
Why?
|
Specimen Handling | 1 | 2010 | 703 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 628 | 0.060 |
Why?
|
Collagenases | 1 | 2006 | 222 | 0.060 |
Why?
|
Bacterial Infections | 1 | 1993 | 1406 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2870 | 0.060 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2002 | 696 | 0.060 |
Why?
|
Dogs | 3 | 2001 | 3839 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2012 | 2206 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5883 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2021 | 698 | 0.060 |
Why?
|
Quality Improvement | 2 | 2019 | 3800 | 0.060 |
Why?
|
Rats | 3 | 2018 | 23729 | 0.060 |
Why?
|
Critical Illness | 5 | 2017 | 2722 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2023 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2004 | 72 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10203 | 0.060 |
Why?
|
Sex Factors | 3 | 2017 | 10551 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 449 | 0.060 |
Why?
|
Tumor Burden | 1 | 2010 | 1887 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 1959 | 0.060 |
Why?
|
Debridement | 1 | 2006 | 493 | 0.060 |
Why?
|
Chronic Disease | 4 | 2014 | 9319 | 0.050 |
Why?
|
Cattle | 2 | 2023 | 3849 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 262 | 0.050 |
Why?
|
Cell Line | 2 | 2014 | 15599 | 0.050 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 286 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2013 | 3210 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1926 | 0.050 |
Why?
|
Binding Sites | 2 | 2010 | 6052 | 0.050 |
Why?
|
Urea | 2 | 2015 | 444 | 0.050 |
Why?
|
Microspheres | 2 | 2004 | 785 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13446 | 0.050 |
Why?
|
Disease Progression | 2 | 2012 | 13500 | 0.050 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2013 | 1384 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10764 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2751 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3687 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8539 | 0.050 |
Why?
|
Incidence | 4 | 2014 | 21336 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17640 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2007 | 997 | 0.050 |
Why?
|
Angioplasty | 2 | 2021 | 354 | 0.050 |
Why?
|
Mesenteric Arteries | 2 | 2002 | 178 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 462 | 0.050 |
Why?
|
Gelatin | 1 | 2022 | 220 | 0.050 |
Why?
|
Arm | 1 | 2024 | 590 | 0.050 |
Why?
|
Catheters | 1 | 2024 | 426 | 0.050 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.040 |
Why?
|
Health Care Costs | 1 | 2014 | 3243 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 1125 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1192 | 0.040 |
Why?
|
Recovery of Function | 2 | 2008 | 2977 | 0.040 |
Why?
|
Image Enhancement | 1 | 2011 | 2884 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 345 | 0.040 |
Why?
|
Catheters, Indwelling | 1 | 2002 | 427 | 0.040 |
Why?
|
Graft Rejection | 3 | 2012 | 4446 | 0.040 |
Why?
|
Follow-Up Studies | 11 | 2015 | 39108 | 0.040 |
Why?
|
Models, Economic | 2 | 2014 | 716 | 0.040 |
Why?
|
Femoral Vein | 1 | 2000 | 153 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2021 | 794 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2002 | 1759 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12949 | 0.040 |
Why?
|
Embolization, Therapeutic | 1 | 1989 | 1418 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 836 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2023 | 593 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3531 | 0.040 |
Why?
|
Survival Rate | 7 | 2012 | 12710 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7852 | 0.040 |
Why?
|
Carotid Artery Thrombosis | 1 | 1998 | 50 | 0.040 |
Why?
|
Iron | 1 | 2007 | 1792 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2241 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13635 | 0.040 |
Why?
|
Connective Tissue Growth Factor | 2 | 2009 | 92 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2832 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 1999 | 335 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6478 | 0.040 |
Why?
|
Dextrothyroxine | 1 | 2017 | 6 | 0.040 |
Why?
|
New England | 1 | 2021 | 1053 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1084 | 0.040 |
Why?
|
Adipocytes | 1 | 2024 | 1192 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2018 | 172 | 0.040 |
Why?
|
Hydrolysis | 1 | 2018 | 665 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 18962 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2010 | 2299 | 0.040 |
Why?
|
Microfluidics | 1 | 2022 | 653 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11900 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6525 | 0.030 |
Why?
|
Hydrogels | 1 | 2022 | 721 | 0.030 |
Why?
|
Connexins | 1 | 2018 | 352 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2610 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7389 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 420 | 0.030 |
Why?
|
Apolipoproteins | 1 | 2018 | 326 | 0.030 |
Why?
|
Food | 1 | 2021 | 772 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2062 | 0.030 |
Why?
|
Immunoglobulin G | 2 | 2005 | 4550 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 502 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2023 | 2115 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2022 | 936 | 0.030 |
Why?
|
Propensity Score | 2 | 2015 | 1908 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 518 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3603 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2018 | 293 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2017 | 245 | 0.030 |
Why?
|
Antirheumatic Agents | 1 | 2005 | 1371 | 0.030 |
Why?
|
Inguinal Canal | 3 | 1999 | 71 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3097 | 0.030 |
Why?
|
Growth Hormone | 1 | 2017 | 569 | 0.030 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2017 | 363 | 0.030 |
Why?
|
Gingiva | 1 | 2017 | 409 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13355 | 0.030 |
Why?
|
Workload | 1 | 2020 | 844 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15499 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2017 | 621 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2018 | 365 | 0.030 |
Why?
|
Blood Cell Count | 1 | 1995 | 397 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 617 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1842 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4321 | 0.030 |
Why?
|
Blood Pressure | 3 | 2021 | 8485 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2002 | 1901 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2017 | 1540 | 0.030 |
Why?
|
Algorithms | 2 | 2006 | 14025 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2008 | 1571 | 0.030 |
Why?
|
Biliary Tract Diseases | 1 | 1994 | 158 | 0.030 |
Why?
|
Actins | 1 | 2001 | 2051 | 0.030 |
Why?
|
Yeasts | 1 | 2014 | 279 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2015 | 276 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 621 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1403 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2017 | 598 | 0.030 |
Why?
|
Hospital Mortality | 3 | 2021 | 5291 | 0.030 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2012 | 44 | 0.030 |
Why?
|
Hirudins | 1 | 1994 | 179 | 0.030 |
Why?
|
Cell Adhesion | 2 | 2004 | 3089 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2853 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1993 | 306 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1504 | 0.030 |
Why?
|
Computer Simulation | 3 | 2014 | 6236 | 0.020 |
Why?
|
Forecasting | 3 | 2013 | 2928 | 0.020 |
Why?
|
Angiography | 3 | 2005 | 1599 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2014 | 374 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2017 | 891 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1703 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2002 | 2093 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 420 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1186 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2442 | 0.020 |
Why?
|
Receptors, Leptin | 1 | 2012 | 350 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2005 | 9180 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20555 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1633 | 0.020 |
Why?
|
Genes | 1 | 1995 | 1844 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15262 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1069 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1647 | 0.020 |
Why?
|
Rats, Inbred Strains | 2 | 1989 | 2090 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14665 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1121 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2319 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1445 | 0.020 |
Why?
|
Cysteine | 1 | 2014 | 892 | 0.020 |
Why?
|
Warfarin | 1 | 1998 | 1483 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 1994 | 504 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2004 | 3441 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12144 | 0.020 |
Why?
|
Angiotensin II | 1 | 2012 | 849 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1689 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1792 | 0.020 |
Why?
|
Electric Impedance | 1 | 2014 | 756 | 0.020 |
Why?
|
Radiography | 3 | 2003 | 6966 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1931 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15835 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 151 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26108 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2009 | 145 | 0.020 |
Why?
|
Hospital Charges | 2 | 2001 | 351 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2009 | 166 | 0.020 |
Why?
|
Cortisone | 1 | 1989 | 87 | 0.020 |
Why?
|
Databases as Topic | 1 | 2011 | 473 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1073 | 0.020 |
Why?
|
Liver Circulation | 1 | 1989 | 159 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2013 | 2265 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3428 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 1995 | 1989 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1899 | 0.020 |
Why?
|
Fibrinolytic Agents | 2 | 1998 | 2082 | 0.020 |
Why?
|
Staphylococcus aureus | 2 | 1993 | 1459 | 0.020 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 1988 | 14 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1656 | 0.020 |
Why?
|
Cell Communication | 1 | 2015 | 1657 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1989 | 818 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2009 | 302 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2000 | 9534 | 0.020 |
Why?
|
Life Expectancy | 1 | 2014 | 1242 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2060 | 0.020 |
Why?
|
Resource Allocation | 1 | 2010 | 350 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5776 | 0.020 |
Why?
|
Skin | 1 | 2001 | 4482 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3843 | 0.020 |
Why?
|
Antibodies | 1 | 2015 | 2421 | 0.020 |
Why?
|
Fistula | 1 | 1989 | 212 | 0.020 |
Why?
|
Hot Temperature | 1 | 1993 | 1441 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3460 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1877 | 0.020 |
Why?
|
Fourier Analysis | 1 | 1988 | 441 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2648 | 0.020 |
Why?
|
Blood Volume | 1 | 1988 | 548 | 0.020 |
Why?
|
Adult | 8 | 2019 | 221122 | 0.020 |
Why?
|
Membrane Fluidity | 1 | 1986 | 68 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2009 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1813 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2009 | 1097 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 1711 | 0.020 |
Why?
|
Microvilli | 1 | 1986 | 234 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2014 | 1456 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2010 | 11098 | 0.020 |
Why?
|
Stem Cells | 1 | 2018 | 3521 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2897 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2189 | 0.020 |
Why?
|
Elasticity | 1 | 2007 | 655 | 0.010 |
Why?
|
Heart Diseases | 1 | 2017 | 2785 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2019 | 12329 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2650 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1993 | 1409 | 0.010 |
Why?
|
Ovary | 1 | 1989 | 959 | 0.010 |
Why?
|
Aging | 2 | 2017 | 8704 | 0.010 |
Why?
|
Blood Platelets | 1 | 1995 | 2481 | 0.010 |
Why?
|
Compliance | 1 | 2003 | 100 | 0.010 |
Why?
|
Rheology | 1 | 2004 | 348 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3806 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2008 | 529 | 0.010 |
Why?
|
Retroperitoneal Space | 1 | 2003 | 170 | 0.010 |
Why?
|
Anticoagulants | 1 | 1998 | 4813 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6595 | 0.010 |
Why?
|
Fibrosis | 1 | 2009 | 2048 | 0.010 |
Why?
|
Renal Circulation | 1 | 2002 | 291 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29588 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4921 | 0.010 |
Why?
|
Gene Deletion | 1 | 2009 | 2667 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2010 | 961 | 0.010 |
Why?
|
Kinetics | 1 | 1989 | 6374 | 0.010 |
Why?
|
Leukocytes | 1 | 2009 | 2029 | 0.010 |
Why?
|
Young Adult | 3 | 2013 | 59196 | 0.010 |
Why?
|
Laparotomy | 1 | 2003 | 457 | 0.010 |
Why?
|
Neutrophils | 1 | 1993 | 3765 | 0.010 |
Why?
|
Axillary Artery | 1 | 2000 | 47 | 0.010 |
Why?
|
Health Status | 1 | 2014 | 4075 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2004 | 1825 | 0.010 |
Why?
|
Random Allocation | 1 | 2004 | 2389 | 0.010 |
Why?
|
Research | 1 | 2008 | 1977 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22158 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2011 | 20092 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8837 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8312 | 0.010 |
Why?
|
Florida | 1 | 1999 | 431 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1989 | 3027 | 0.010 |
Why?
|
Probability | 1 | 2003 | 2478 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11531 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1997 | 119 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1986 | 2163 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15719 | 0.010 |
Why?
|
Perioperative Care | 1 | 2003 | 1034 | 0.010 |
Why?
|
Hospitals, General | 1 | 1999 | 798 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5866 | 0.010 |
Why?
|
Chromogenic Compounds | 1 | 1994 | 31 | 0.010 |
Why?
|
Spinal Cord Injuries | 1 | 2002 | 925 | 0.010 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 170 | 0.010 |
Why?
|
Plasminogen | 1 | 1994 | 146 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1058 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1999 | 2927 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5491 | 0.010 |
Why?
|
Textiles | 1 | 1993 | 45 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 1545 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 201 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1995 | 686 | 0.010 |
Why?
|
Child | 1 | 2021 | 80156 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6178 | 0.010 |
Why?
|
Retinoblastoma | 1 | 1995 | 317 | 0.010 |
Why?
|
Dipeptides | 1 | 1994 | 391 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1992 | 374 | 0.010 |
Why?
|
Aorta | 1 | 1999 | 2042 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9275 | 0.010 |
Why?
|
Thrombin | 1 | 1994 | 590 | 0.010 |
Why?
|
Data Collection | 1 | 2001 | 3324 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1995 | 1992 | 0.010 |
Why?
|
Heparin | 1 | 1998 | 1633 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1994 | 686 | 0.010 |
Why?
|
Coloring Agents | 1 | 1993 | 559 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1994 | 1793 | 0.010 |
Why?
|
Heart Failure | 1 | 2014 | 11672 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1995 | 4175 | 0.010 |
Why?
|
Survival Analysis | 1 | 2001 | 10075 | 0.000 |
Why?
|
Oligopeptides | 1 | 1994 | 1186 | 0.000 |
Why?
|
Hospitals | 1 | 2001 | 3878 | 0.000 |
Why?
|
Aspirin | 1 | 1998 | 3134 | 0.000 |
Why?
|
Diphenylhexatriene | 1 | 1986 | 12 | 0.000 |
Why?
|
Microbial Sensitivity Tests | 1 | 1993 | 1956 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1995 | 3159 | 0.000 |
Why?
|
alpha-Glucosidases | 1 | 1986 | 45 | 0.000 |
Why?
|
Fluorescence Polarization | 1 | 1986 | 140 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6086 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12449 | 0.000 |
Why?
|
Maternal-Fetal Exchange | 1 | 1986 | 463 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1999 | 5439 | 0.000 |
Why?
|
Protein Binding | 1 | 1994 | 9351 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7597 | 0.000 |
Why?
|
Animals, Newborn | 1 | 1986 | 2678 | 0.000 |
Why?
|
Temperature | 1 | 1986 | 2229 | 0.000 |
Why?
|
Dexamethasone | 1 | 1986 | 1946 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1986 | 1815 | 0.000 |
Why?
|
Gestational Age | 1 | 1986 | 3576 | 0.000 |
Why?
|
Child, Preschool | 1 | 1992 | 42251 | 0.000 |
Why?
|
Pregnancy | 1 | 1986 | 29858 | 0.000 |
Why?
|